Corporate presentation scheduled for Tuesday, February 11, 2025 at 10:15 AM EST CARMIEL, Israel , Feb. 4, 2025

CARMIEL, Israel , Dec. 23, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE-American: PLX), a biophar

Application to label a less frequent dosing regimen at a dose of 2 mg/kg body weight administered every four w